Caps Home

SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN)

CAPS Game Rating: 4 out of 5

A biopharmaceutical company, which is engaged in the development and commercialization of novel therapeutics to treat life-threatening diseases.

Quote
Commentary
Scorecard
Historical Prices
Chart
Stats
Ratios
Earnings/Growth Rates
Statements
SEC Filings

For details about CAPS-UK, and the conditions you agree to be bound by, please see our Terms and Conditions.

Browse our site by topic area

Search our site in seconds

© Copyright 1998-2013, The Motley Fool Limited. All rights reserved. This material is for personal use only.
The Motley Fool, Fool, and the "Fool" logo are registered trademarks of The Motley Fool, Holdings, Inc.
Place of Reg: England & Wales. Company Reg No: 3736872. VAT Reg No: 945 6990 68. Registered Office: 5th Floor, 60 Charlotte Street London W1T 2NU.

This page brought to you by USEQ\WEB22.

Enter Ticker

SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN)

Browse our site by topic area

Award-Winning Content

The Motley Fool Services

Who We Are

Fool.co.uk Community

Support

Search our site in seconds